Columbus Foot Clinic | |
2724 13th St, Columbus, NE 68601-4917 | |
(402) 563-3668 | |
(402) 563-3669 |
Full Name | Columbus Foot Clinic |
---|---|
Type | Facility |
Speciality | Podiatrist |
Location | 2724 13th St, Columbus, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437148525 | NPI | - | NPPES |
2537 | Other | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | 139 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Columbus Foot Clinic 2724 13th St, Columbus, NE 68601-4917 Ph: (402) 563-3668 | Columbus Foot Clinic 2724 13th St, Columbus, NE 68601-4917 Ph: (402) 563-3668 |
News Archive
In a novel study the authors hope will contribute to improved patient care, Richard L. Roudebush Veterans Affairs Medical Center and Regenstrief Institute researchers examine how Black patients with mental health concerns evaluate verbal and non-verbal communication during treatment.
Large corporations could save millions of dollars in lost productivity by screening and treating high-risk employees for obstructive sleep apnea, suggests a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC.
In an effort to raise local and national awareness about the importance—and ease—of HIV testing and to challenge attitudes about moving toward a streamlined model of HIV testing and counseling nationwide, AIDS Healthcare Foundation (AHF) is proud to report its launch of a second HIV Testing Tour across the US after its successful completion of its recent and ambitious 14 city AHF Magic Johnson HIV Testing Caravan in mid-2009.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced that it has notified the US Food and Drug Administration (FDA) that the company has placed a voluntary hold on PEARL-SC, the Phase 2b study of A-623 for the treatment of Systemic Lupus Erythematosus (lupus), due to problems found with product vials.
› Verified 3 days ago
Dr. Brandon L Borer, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4508 38th St, Suite 133, Columbus, NE 68601 Phone: 402-562-4700 Fax: 402-562-4701 |